SCHEMBL251669

SCHEMBL251669

CCCCCN1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10885201 0.97 HRH3 (0.62)
SCHEMBL1788911 0.97 HRH3 (0.62)
SCHEMBL768306 0.97 HRH3 (0.62)
Water SCHEMBL7828726 0.97 GNAI3 (0.56)
SCHEMBL20033703 0.97 HRH3 (0.62)
SCHEMBL28384304 0.97 HRH3 (0.62)
SCHEMBL29385011 0.97 HRH3 (0.62)
SCHEMBL7478832 0.97 HRH3 (0.62)
SCHEMBL22121638 0.97 HRH3 (0.62)
Hydrochloric Acid SCHEMBL4249145 0.95 GNAO1 (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4355729-A1 AZETIDINYL COMPOUNDS COMPRISING A CARBOXYLIC ACID GROUP FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Celgene Corporation (US) 2024-04-24 EP disclosed
US-11919879-B2 Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases CELGENE CORPORATION (US) 2024-03-05 US disclosed
CN-117500785-A Azetidinyl-containing carboxylic acid compounds for the treatment of neurodegenerative diseases 细胞基因公司 2024-02-02 CN disclosed
WO-2023247670-A1 NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2023-12-28 WO disclosed
US-20230028747-A1 Carboxylic Acid Containing Azetidinyl Compounds for the Treatment of Neurodegenerative Diseases CELGENE CORPORATION (US) 2023-01-26 US disclosed
WO-2022266162-A1 AZETIDINYL COMPOUNDS COMPRISING A CARBOXYLIC ACID GROUP FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES CELGENE CORPORATION (US) 2022-12-22 WO disclosed
CN-108484468-A The preparation method of aryl azetidin compounds 南京大学 2018-09-04 CN disclosed
CN-108484468-A The preparation method of aryl azetidin compounds 南京大学 2018-09-04 CN disclosed
EP-2601190-B1 ISOXAZOLINE DERIVATIVES AS ANTIPARASITIC AGENTS ZOETIS SERVICES LLC (US) 2018-07-04 EP disclosed
US-20170334841-A1 TETRACYCLINE COMPOUNDS TETRAPHASE PHARMACEUTICALS, INC. 2017-11-23 US disclosed
WO-2000075203-A1 PROCESS FOR PRODUCING ETHYLENE/OLEFIN INTERPOLYMERS EASTMAN CHEMICAL COMPANY (US) 2000-12-14 WO disclosed
WO-2000075202-A1 PROCESS FOR PRODUCING ETHYLENE/OLEFIN INTERPOLYMERS EASTMAN CHEMICAL COMPANY (US) 2000-12-14 WO disclosed
WO-2000052068-A1 PROCESS FOR PRODUCING POLYETHYLENE EASTMAN CHEMICAL COMPANY (US) 2000-09-08 WO disclosed
EP-0900236-A1 PHOTOPOLYMERIZATION REACTIONS INDUCED BY CHEMILUMINESCENCE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-03-10 EP disclosed
WO-1997033922-A1 PHOTOPOLYMERIZATION REACTIONS INDUCED BY CHEMILUMINESCENCE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-09-18 WO disclosed
US-5494944-A BLEND OF MATERIAL POLYMERIZABLE BY FREE RADICAL CATALYSTAND AN IRON COMPOUND CIBA-GEIGY CORPORATION (US) 1996-02-27 US disclosed
US-5371115-A Having sensitizers, electron acceptors selected from peracids, hydroperoxides and quinones; photosensitive, photoresists CIBA-GEIGY CORPORATION (US) 1994-12-06 US disclosed
US-5073476-A Containing iron aromatic complex and oxidizer CIBA-GEIGY CORPORATION (US) 1991-12-17 US disclosed
EP-0375527-A1 N-aryl-azetidinones, process for their preparation and their use as elastase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1990-06-27 EP disclosed
US-4868288-A TITANIUM TETRACHLORIDE CATALYST CIBA-GEIGY CORPORATION (US) 1989-09-19 US disclosed